These 3 Things Could Send Novavax's Stock Soaring to New Heights

If you had bought Novavax (NASDAQ: NVAX) stock at the beginning of the year, you would be a happy investor right now. Shares of this biotech company have skyrocketed by almost 2,000% year to date, a rare feat even within the volatile biotech industry. Novavax has been able to achieve these returns thanks to its involvement in the hunt for a vaccine for COVID-19.

It's natural to wonder whether now is a good time to cash in on Novavax; after all, no one can argue with gains like that%. However, if Novavax continues to climb, it might make more sense to hold on to its shares, even after its dazzling run since the beginning of the year. With that in mind, here are three things that could cause Novavax's stock to jump even higher.